The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glycated Haemoglobin Testing-Global Market Insights and Sales Trends 2024
Synopsis
Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.
The global Glycated Haemoglobin Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Glycated Haemoglobin Testing in various end use industries. The expanding demands from the Hospitals, Diagnostic Centers, Academic and Research Institutes and Others, are propelling Glycated Haemoglobin Testing market. Lab Based Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Point-of-care Test segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycated Haemoglobin Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycated Haemoglobin Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycated Haemoglobin Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycated Haemoglobin Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycated Haemoglobin Testing covered in this report include Bio-Rad Laboratories, Bayer, Arkray, Chek Diagnostics, Diazyme Laboratories, X Lite-On Technology, TaiDoc Technology, Trinity Biotech and Siemens Healthcare, etc.
The global Glycated Haemoglobin Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Global Glycated Haemoglobin Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycated Haemoglobin Testing market, Segment by Type:
Lab Based Test
Point-of-care Test
Global Glycated Haemoglobin Testing market, by Application
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glycated Haemoglobin Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.
The global Glycated Haemoglobin Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Glycated Haemoglobin Testing in various end use industries. The expanding demands from the Hospitals, Diagnostic Centers, Academic and Research Institutes and Others, are propelling Glycated Haemoglobin Testing market. Lab Based Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Point-of-care Test segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycated Haemoglobin Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycated Haemoglobin Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycated Haemoglobin Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycated Haemoglobin Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycated Haemoglobin Testing covered in this report include Bio-Rad Laboratories, Bayer, Arkray, Chek Diagnostics, Diazyme Laboratories, X Lite-On Technology, TaiDoc Technology, Trinity Biotech and Siemens Healthcare, etc.
The global Glycated Haemoglobin Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Global Glycated Haemoglobin Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycated Haemoglobin Testing market, Segment by Type:
Lab Based Test
Point-of-care Test
Global Glycated Haemoglobin Testing market, by Application
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glycated Haemoglobin Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Glycated Haemoglobin Testing
1.1 Glycated Haemoglobin Testing Market Overview
1.1.1 Glycated Haemoglobin Testing Product Scope
1.1.2 Glycated Haemoglobin Testing Market Status and Outlook
1.2 Global Glycated Haemoglobin Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Glycated Haemoglobin Testing Market Size by Region (2018-2029)
1.4 Global Glycated Haemoglobin Testing Historic Market Size by Region (2018-2023)
1.5 Global Glycated Haemoglobin Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Glycated Haemoglobin Testing Market Size (2018-2029)
1.6.1 North America Glycated Haemoglobin Testing Market Size (2018-2029)
1.6.2 Europe Glycated Haemoglobin Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Glycated Haemoglobin Testing Market Size (2018-2029)
1.6.4 Latin America Glycated Haemoglobin Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Glycated Haemoglobin Testing Market Size (2018-2029)
2 Glycated Haemoglobin Testing Market by Type
2.1 Introduction
2.1.1 Lab Based Test
2.1.2 Point-of-care Test
2.2 Global Glycated Haemoglobin Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Glycated Haemoglobin Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Glycated Haemoglobin Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Glycated Haemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Glycated Haemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Glycated Haemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Glycated Haemoglobin Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Glycated Haemoglobin Testing Revenue Breakdown by Type (2018-2029)
3 Glycated Haemoglobin Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Centers
3.1.3 Academic and Research Institutes
3.1.4 Others
3.2 Global Glycated Haemoglobin Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Glycated Haemoglobin Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Glycated Haemoglobin Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Glycated Haemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Glycated Haemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Glycated Haemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Glycated Haemoglobin Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Glycated Haemoglobin Testing Revenue Breakdown by Application (2018-2029)
4 Glycated Haemoglobin Testing Competition Analysis by Players
4.1 Global Glycated Haemoglobin Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glycated Haemoglobin Testing as of 2022)
4.3 Date of Key Players Enter into Glycated Haemoglobin Testing Market
4.4 Global Top Players Glycated Haemoglobin Testing Headquarters and Area Served
4.5 Key Players Glycated Haemoglobin Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Glycated Haemoglobin Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Rad Laboratories
5.1.1 Bio-Rad Laboratories Profile
5.1.2 Bio-Rad Laboratories Main Business
5.1.3 Bio-Rad Laboratories Glycated Haemoglobin Testing Products, Services and Solutions
5.1.4 Bio-Rad Laboratories Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Rad Laboratories Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Glycated Haemoglobin Testing Products, Services and Solutions
5.2.4 Bayer Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Arkray
5.3.1 Arkray Profile
5.3.2 Arkray Main Business
5.3.3 Arkray Glycated Haemoglobin Testing Products, Services and Solutions
5.3.4 Arkray Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Chek Diagnostics Recent Developments
5.4 Chek Diagnostics
5.4.1 Chek Diagnostics Profile
5.4.2 Chek Diagnostics Main Business
5.4.3 Chek Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
5.4.4 Chek Diagnostics Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Chek Diagnostics Recent Developments
5.5 Diazyme Laboratories
5.5.1 Diazyme Laboratories Profile
5.5.2 Diazyme Laboratories Main Business
5.5.3 Diazyme Laboratories Glycated Haemoglobin Testing Products, Services and Solutions
5.5.4 Diazyme Laboratories Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Diazyme Laboratories Recent Developments
5.6 X Lite-On Technology
5.6.1 X Lite-On Technology Profile
5.6.2 X Lite-On Technology Main Business
5.6.3 X Lite-On Technology Glycated Haemoglobin Testing Products, Services and Solutions
5.6.4 X Lite-On Technology Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.6.5 X Lite-On Technology Recent Developments
5.7 TaiDoc Technology
5.7.1 TaiDoc Technology Profile
5.7.2 TaiDoc Technology Main Business
5.7.3 TaiDoc Technology Glycated Haemoglobin Testing Products, Services and Solutions
5.7.4 TaiDoc Technology Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.7.5 TaiDoc Technology Recent Developments
5.8 Trinity Biotech
5.8.1 Trinity Biotech Profile
5.8.2 Trinity Biotech Main Business
5.8.3 Trinity Biotech Glycated Haemoglobin Testing Products, Services and Solutions
5.8.4 Trinity Biotech Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Trinity Biotech Recent Developments
5.9 Siemens Healthcare
5.9.1 Siemens Healthcare Profile
5.9.2 Siemens Healthcare Main Business
5.9.3 Siemens Healthcare Glycated Haemoglobin Testing Products, Services and Solutions
5.9.4 Siemens Healthcare Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Siemens Healthcare Recent Developments
5.10 Ceragem Medisys
5.10.1 Ceragem Medisys Profile
5.10.2 Ceragem Medisys Main Business
5.10.3 Ceragem Medisys Glycated Haemoglobin Testing Products, Services and Solutions
5.10.4 Ceragem Medisys Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Ceragem Medisys Recent Developments
5.11 Tosoh Bioscience
5.11.1 Tosoh Bioscience Profile
5.11.2 Tosoh Bioscience Main Business
5.11.3 Tosoh Bioscience Glycated Haemoglobin Testing Products, Services and Solutions
5.11.4 Tosoh Bioscience Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Tosoh Bioscience Recent Developments
5.12 DiaSys Diagnostic Systems
5.12.1 DiaSys Diagnostic Systems Profile
5.12.2 DiaSys Diagnostic Systems Main Business
5.12.3 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Products, Services and Solutions
5.12.4 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.12.5 DiaSys Diagnostic Systems Recent Developments
5.13 Erba Mannheim
5.13.1 Erba Mannheim Profile
5.13.2 Erba Mannheim Main Business
5.13.3 Erba Mannheim Glycated Haemoglobin Testing Products, Services and Solutions
5.13.4 Erba Mannheim Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Erba Mannheim Recent Developments
5.14 Daiichi Biotech
5.14.1 Daiichi Biotech Profile
5.14.2 Daiichi Biotech Main Business
5.14.3 Daiichi Biotech Glycated Haemoglobin Testing Products, Services and Solutions
5.14.4 Daiichi Biotech Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Daiichi Biotech Recent Developments
5.15 Human Diagnostics
5.15.1 Human Diagnostics Profile
5.15.2 Human Diagnostics Main Business
5.15.3 Human Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
5.15.4 Human Diagnostics Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Human Diagnostics Recent Developments
5.16 EKF Diagnostics
5.16.1 EKF Diagnostics Profile
5.16.2 EKF Diagnostics Main Business
5.16.3 EKF Diagnostics Glycated Haemoglobin Testing Products, Services and Solutions
5.16.4 EKF Diagnostics Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.16.5 EKF Diagnostics Recent Developments
5.17 Mindray Medical
5.17.1 Mindray Medical Profile
5.17.2 Mindray Medical Main Business
5.17.3 Mindray Medical Glycated Haemoglobin Testing Products, Services and Solutions
5.17.4 Mindray Medical Glycated Haemoglobin Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Mindray Medical Recent Developments
6 North America
6.1 North America Glycated Haemoglobin Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Glycated Haemoglobin Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Glycated Haemoglobin Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Glycated Haemoglobin Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Glycated Haemoglobin Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Glycated Haemoglobin Testing Market Dynamics
11.1 Glycated Haemoglobin Testing Industry Trends
11.2 Glycated Haemoglobin Testing Market Drivers
11.3 Glycated Haemoglobin Testing Market Challenges
11.4 Glycated Haemoglobin Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
